views
Asia Pacific Interventional Cardiology Devices Market
MARKET ANALYSIS & SEGMENT FORECAST FROM 2021 TO 2027The report covers 4 countries within Asia Pacific, segregated into four countries, India, China, Japan, and South Korea. These are the countries in Asia Pacific where the robust growth of interventional cardiology devices market adoption was observed in the past and is expected to register growth during the forecast period due to increasing Angiography procedures, supportive regulations and laws, and increasing awareness about healthcare procedures. Also, key drivers of all the countries are included in the report which indicates the favorable opportunities for companies to enter into these markets.
The Asia Pacific interventional cardiology devices market was valued at USD 4,268.5 Million in 2020 and is expected to grow at a CAGR of 3.9% over the forecast period. The changing insurance coverage coupled with rising awareness about patient benefits is expected to drive the market during the forecast period. Countries like China and India is developing price control program for these medical devices. This trend is expected to contribute to slower growth of interventional cardiology devices market in the foreseeable future. Presence of end-to-end manufacturers that are engaged in providing value-added services for minimum profit margins is expected to bolster growth.
Company Profiles
-
BOSTON SCIENTIFIC
-
MEDTRONIC
-
ABBOTT
-
NORDSON MEDICAL
-
TERUMO CORPORATION
-
COOK GROUP
-
STENTYS SA